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Objectives. We sought to determine whether the amount of
myocardial ischemic burden differs in patients with painful or
silent myocardial hypoperfusion during exercise testing.
Background. Whether a lack of symptoms during ischemia
reflects an alteration in pain perception or less myocardium in
jeopardy remains a controversial issue.
Methods. We studied 300 consecutive patients with a well
established history of ischemic heart disease and reversible
hypoperfusion on exercise sestamibi tomography. Rest and stress
sestamibi defects were quantitatively assessed and indexes of
exercise left ventricular dilation derived.
Results. Painful and silent reversible ischemia was observed in
97 (32%) and 203 (68%) patients, respectively. Patients with
painful ischemia had lower values for work load, exercise time and
peak rate-pressure product (p < 0.01) and more frequently
showed significant ST segment depression during exercise than
did patients with silent ischemia (69% vs. 40%, p < 0.001). On
sestamibi tomography, patients with painful ischemia had more
reversible hypoperfusion than did patients with silent ischemia
(mean 6 SD 16 6 10% vs. 11 6 7%, p < 0.001), despite a
comparable extent of stress hypoperfusion (22 6 12% vs. 22 6
13%); they also had a higher endocardial dilation index (1.32 6
0.32 vs. 1.10 6 0.26, p < 0.001). By multivariate logistic analysis,
the most powerful correlate of painful ischemia was a history of
effort angina; the extent of reversible perfusion defect was the sole
independent scintigraphic correlate of painful ischemia.
Conclusions. To our knowledge, this is the largest study com-
paring the degree of hypoperfusion and the presence of symptoms
during exercise stress testing in a consecutive cohort of patients
with ischemic heart disease and reversible hypoperfusion. The
results suggest that the ischemic burden is greater in painful than
in silent ischemia.
(J Am Coll Cardiol 1997;29:948–54)
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The occurrence of painless myocardial ischemia during daily
activity and during exercise testing is common in patients with
coronary artery disease (1–5). Whether the absence of pain
depends on a hampered pain responsiveness or indicates that
the degree of ischemic injury is not severe enough for the
occurrence of pain is still largely debated (6–10), and previous
studies assessing myocardial perfusion during exercise testing
(9,11–19) have reported conflicting results. However, these
studies used miscellaneous criteria in selecting patients, differ-
ent imaging techniques and qualitative or semiquantitative
criteria in interpreting the scintigraphic results.
Accordingly, in a large population of well defined subjects
with ischemic heart disease undergoing exercise technetium-
99m (99mTc) sestamibi myocardial tomography, we used quan-
titative analysis of the scintigraphic perfusion abnormalities to
assess whether the ischemic burden is more severe in patients
with chest pain during exercise than in those with silent
ischemic episodes.
Methods
Study cohort. The study group consisted of 300 consecutive
patients referred between January 1993 and December 1995 to
our nuclear cardiology laboratory for stress-rest 99mTc sesta-
mibi perfusion scintigraphy. This sample of patients was pro-
spectively recruited according to the following selection crite-
ria: 1) documented coronary artery disease based on
angiography or a history of prior myocardial infarction (200
patients, 67%) or a high (.80%) pretest probability of coro-
nary disease according to a Bayesian analysis of risk factors,
symptoms and results of an exercise electrocardiogram (ECG)
(100 patients, 33%) (9); and 2) unequivocal evidence of a
reversible perfusion defect by quantitative criteria on exercise
sestamibi tomography. The diagnosis of previous myocardial
infarction was supported by a history of prolonged chest pain
associated with a typical pattern of serum myocardial enzyme
and evolutionary ECG changes. Patients with an uninterpret-
able ECG were excluded, as were those with rest ST segment
abnormalities, conduction disturbances or left ventricular hy-
pertrophy. Patients with recent myocardial infarction (,30
days) and those receiving digoxin were also excluded, as well as
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subjects who did not achieve a symptom-limited end point
during exercise testing.
Exercise testing. Rest and exercise scans were performed
in random in a 2-day imaging protocol. All rest studies were
performed while the patient was receiving full therapy. All
patients underwent a multistage symptom-limited exercise test
in the upright position after an overnight fast and with
medications withheld $12 h before stress testing; a 12-lead
ECG was recorded every 1 min and blood pressure every
3 min. The work load was increased by 25 W every 3 min and
patients exercised until they achieved the maximal predicted
heart rate, reported exercise-limiting fatigue, chest pain, dys-
pnea or hypotension or had complex ventricular arrhythmias
or $0.3 mV downsloping or horizontal ST segment depression.
Throughout the exercise study and in the recovery period,
patients were questioned by the cardiologist who supervised
the test (C.M., M.G.) concerning the development of typical
chest discomfort or any other clear anginal equivalent (i.e.,
pain in the neck, jaw, throat or arms). At peak exercise the
tracer was injected, after which patients were encouraged to
continue exercising for 60 to 90 s. An ECG response was
defined as positive for ischemia if there was horizontal or
downsloping ST segment depression $0.1 mV for $80 ms
after the J point and for $3 consecutive beats.
Sestamibi images acquisition and processing. After the
tracer injection (925 MBq/70 kg for both rest and stress
studies), a light meal was provided to accelerate hepatobiliary
clearance of the tracer and to improve the heart/background
ratio. Scintigraphic image acquisition was performed within
60 min of tracer injection with use of a rotating camera (SP-6,
Elscint, Israel) equipped with a high resolution parallel hole
collimator and a 610% energy window centered on the
140-keV photopeak. The camera head was rotated in a 180° arc
in a circular orbit from the 30° right anterior oblique angle to
the 30° left posterior angle with 3° increments every 20 s, in
step-and-shoot mode. Data were collected in a 64 3 64 array.
Care was taken to avoid major artifacts, such as patient motion
during acquisition. Transaxial slices were reconstructed by
using a filtered back-projection algorithm with a modified
Wiener filter, without attenuation or scatter correction; flood
correction was applied during reconstruction. Short-axis and
long-axis (horizontal and vertical) tomograms were recon-
structed from the transaxial slices. All studies were processed
by an experienced operator who was unaware of the patients’
clinical and functional data. Quantitative analysis of myocar-
dial sestamibi distribution was performed as previously de-
scribed (20). From the transaxial sections, slices in the short-
axis view were reconstructed, and the polar map of the regional
sestamibi distribution was normalized for peak myocardial
activity and compared with the normal limits obtained in 50
gender-matched subjects with ,5% probability of coronary
artery disease. Pixels with tracer uptake falling .2.5 SD below
mean normal values were considered abnormal. Abnormal
areas were corrected for spatial distortion (20) and then
summed to obtain total left ventricular defect size at rest and
after exercise, expressed as a percent of the left ventricular
surface. A perfusion defect observed on the exercise study was
considered reversible when changes in defect size from the
stress to the rest scan exceeded the 95% confidence limits of
the method variability (i.e., 4.8% of the left ventricular sur-
face), as previously determined (20). A change in the extent of
the perfusion defect from rest to exercise $15% of the total
left ventricular surface was arbitrarily defined as severe exer-
tional ischemia.
The epicardial and endocardial contours of the midven-
tricular short-axis slice on rest and exercise images were
automatically drawn; the corresponding areas were computed
and the exercise/rest area ratios were calculated and defined as
epicardial and endocardial transient dilation indexes (TDI),
respectively.
Statistical analysis. Data are reported as mean value 6SD
for continuous variables and as a proportion for categoric
variables. Univariate analysis of categoric variables was per-
formed by using chi-square analysis or the Fisher exact test.
Comparisons of continuous data between groups were made by
using the Student t test for unpaired data or one-way analysis
of variance (ANOVA) for factorial analysis with the Scheffe´ F
test. A stepwise logistic regression analysis (BMPD Statistical
Software) was used to assess the independent value of the
significant clinical, ergometric and scintigraphic univariate
correlates of painful perfusion defects. A p value ,0.05
(two-tailed) was considered significant.
Results
Patient characteristics. The study group consisted of 300
patients (259 men [86%]) with a mean age of 57 6 9 years
(range 33 to 79). A history of stable angina pectoris was
present in 124 patients (41%); 152 patients (51%) had had a
prior myocardial infarction. Coronary angiography, available
in 141 patients (47%), showed significant stenosis ($50%
lumen diameter reduction) of one major coronary vessel in 46
patients (33%); 92 other patients (65%) had multiple vessel
disease. By inclusion criteria, all patients had reversible perfu-
sion defects. On the basis of the clinical response to exercise,
patients were classified into those with chest pain during
exercise (97 patients [32%]) and those without chest pain (203
patients [68%]). Table 1 lists pertinent demographic, clinical
and angiographic results from the two groups. Age and coro-
nary anatomy were similar in both groups; patients with painful
ischemia more frequently had a history of effort angina and
those with silent ischemia a history of previous myocardial
infarction.
Exercise test results. Table 2 compares exercise data in
patients with painful or silent ischemia. Patients with painful
Abbreviations and Acronyms
ECG 5 electrocardiogram, electrocardiographic
TDI 5 transient dilation index
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ischemia exercised for a shorter time, achieving significantly
lower values for work load, peak exercise heart rate and peak
rate-pressure product. They also showed significant ST seg-
ment depression during exercise more frequently than did
patients with silent ischemia and had a significantly shorter
time to onset of ST segment depression.
Scintigraphic findings. Table 2 also reports the scinti-
graphic results for the two groups. The total extent of myocar-
dial hypoperfusion on exercise sestamibi tomography was
comparable in the two groups; however, the amount of revers-
ible ischemia (i.e., the difference between stress and rest tracer
uptake defect extent) was significantly greater in patients with
painful ischemia. Figure 1 shows plots of the distribution of
reversible sestamibi defect extent according to the presence or
absence of chest pain during exercise. Severe exertional isch-
emia was also more common in patients with painful ischemia
(Table 2); these patients also had a significantly greater
endocardial TDI although epicardial TDI was similar in the
two groups.
During exercise, 75 patients (25%) had both chest pain and
significant ECG changes; 122 other patients (41%) showed
reversible sestamibi defects in the absence of both symptoms
and ECG changes. The remaining 103 patients showed silent
ECG changes (81 patients, 27%) or typical chest pain in the
absence of ECG signs of ischemia (22 patients, 7%). The total
extent of exercise sestamibi defect was comparable among all
four categories; however, patients with both chest pain and
ECG changes during exercise showed the largest reversible
defect and the greatest endocardial TDI (p , 0.01) (Fig. 2).
Figure 3 shows the extent of reversible perfusion defect and
endocardial TDI in different clinical subgroups of patients
(previous myocardial infarction, presence of ECG signs of
ischemia, single vs. multiple vessel disease) with respect to the
presence of exertional angina. In all subgroups, patients with
Table 1. Clinical Findings in Patients With Painful or Silent
Reversible Sestamibi Perfusion Defects During Exercise
Painful
Ischemia
(n 5 97 [32%])
Silent
Ischemia
(n 5 203 [68%])
p
Value
Age (yr) 58 6 8 56 6 10 NS
Male/female 77/20 182/21 NS
History
Hypertension 23 (24%) 56 (27%) NS
Diabetes 5 (5%) 11 (5%) NS
Hypercholesterolemia 24 (25%) 52 (26%) NS
Body mass index (kg/m2) 27 6 3 25 6 3 , 0.001
Previous MI 36 (37%) 116 (57%) , 0.05
Effort angina 71 (73%) 53 (26%) , 0.001
Rest and effort angina 13 (13%) 16 (8%) NS
Medications
Nitrates 49 (51%) 69 (34%) , 0.01
Beta-blockers 46 (47%) 73 (36%) , 0.01
Calcium antagonists 41 (42%) 59 (29%) , 0.01
Angiography 46 95
Single-vessel disease 14 (32%) 32 (34%)
Multivessel disease 30 (68%) 62 (66%) NS
Occluded vessels 25 (54%) 36 (38%) 0.09
Proximal LAD occlusion 5 (11%) 10 (11%) NS
Left ventricular ejection fraction* 55 6 11 52 6 12 NS
*On biplane two-dimensional echocardiography or contrast ventriculogra-
phy. Data are reported as mean values 6SD or number (%) of patients. LAD 5
left anterior descending coronary artery; MI 5 myocardial infarction.
Table 2. Comparison of Exercise and Scintigraphic Data in Patients
With Painful or Silent Reversible Sestamibi Perfusion Defects
Painful
Ischemia
(n 5 97 [32%])
Silent
Ischemia
(n 5 203 [68%])
p
Value
Exercise stress test
Peak SBP (mm Hg) 189 6 28 193 6 25 , 0.001
D SBP (mm Hg) 45 6 23 56 6 27 , 0.01
Peak RPP
(beats/min 3 mm Hg)
23,798 6 6,275 27,458 6 5,494 , 0.001
% of max age-predicted
HR achieved
73 6 22 81 6 24 , 0.05
METs 4.7 6 1.7 5.8 6 1.8 , 0.001
Positive ECG finding 67 (69%) 81 (40%) , 0.001
Time to 1-mm ST2 (min) 7.1 6 4.5 8.9 6 3.2 , 0.05
Total time to ST2 (*) (min) 11.1 6 5.2 11.3 6 5.5 NS
Amount of ST2 (mm) 2.1 6 0.9 2.0 6 0.7 NS
Sestamibi SPECT
Rest defect extent 5 6 7% 10 6 11% , 0.01
Stress defect extent 22 6 12% 22 6 13% NS
Reversible defect extent 16 6 10% 11 6 7% , 0.001
Severe ischemia 29 (30%) 28 (14%) , 0.001
Endocardial TDI 1.32 6 0.32 1.10 6 0.26 , 0.001
Epicardial TDI 1.0 6 0.12 0.99 6 0.19 NS
Perfusion defect location
LAD territory 41 (42%) 94 (46%) NS
RCA/LCx territory 67 (69%) 153 (75%) NS
*Defined as time of ST segment depression during exercise plus time to full
recovery. Data are reported as mean value 6SD or number (%) of patients.
D SBP 5 change in systolic blood pressure from rest to exercise; ECG 5
electrocardiogram; HR 5 heart rate; LAD 5 left anterior descending coronary
artery; LCx 5 left circumflex coronary artery; max 5 maximal; METs 5
metabolic equivalents; RCA 5 right coronary artery; RPP 5 rate-pressure
product; SBP 5 systolic blood pressure; SPECT 5 single-photon emission computed
tomography; ST2 5 ST segment depression; TDI 5 transient dilation index.
Figure 1. Cumulative frequency distribution of extent of the reversible
technetium-99m sestamibi uptake defect in the 97 patients with (open
circles) and in the 203 patients without (closed circles) chest pain
during exercise.
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painful ischemia had a significantly greater reversible perfusion
defect and endocardial TDI.
When the clinical, ergometric and scintigraphic variables
that correlated significantly with painful ischemia on univariate
analysis were introduced in a logistic regression analysis, a
history of effort angina was found to be the most powerful
predictor of painful ischemia (Table 3). The extent of revers-
ible perfusion defect was the sole scintigraphic variable inde-
pendently correlated with painful ischemia.
Discussion
The subjective recognition of a cardiac ischemic stimulus is
highly variable, and the proposed underlying mechanisms are
still speculative. In particular, it is unclear whether a threshold
of ischemic magnitude plays some role. Failure to experience
angina during exercise-induced silent ischemia could be caused
by inadequacy of the stimulus, due to a lesser amount of
transient ischemic myocardium (1,2,9,10,21). Several other
variables have been related to the absence of chest pain during
ischemia, including the location and duration of the ischemic
episode as well as an altered pain perception and complaint
(6–8,22).
In this study we tested the hypothesis that chest pain during
exercise is associated with a greater ischemic burden (as
determined by quantitative tomographic criteria) than that of
silent episodes. Results from our study indicate that 1) silent
reversible perfusion defects occur frequently; 2) the presence
of chest pain during exercise is associated with a greater
ischemic burden. Furthermore, our data support the conclu-
sion that the more evidence of ischemia patients manifest
during exercise (as reflected by objective and subjective mea-
sures), the greater is their exercise-induced hypoperfusion.
Patients with silent ischemia exercised for a longer time and
achieved higher peak heart rate values and peak rate-pressure
products on exercise testing. Thus, the absence of angina
cannot be ascribed to a suboptimal stress, that is, a level of
stress inadequate to bring out the symptom.
In our study, we found no differences between patients with
painful and silent ischemia in the frequency of hypertension,
diabetes or hypercholesterolemia, although we cannot exclude
that selection bias could have influenced the distribution of
conventional risk factors in this cohort of patients. Patients
with symptomatic reversible hypoperfusion more frequently
had a history of effort angina and, similar to a previous report
(12), patients with healed myocardial infarction (whose peri-
necrotic or remote “anginal warning system,” or both, may
Figure 2. Bar graphs showing the extent of reversible hypoperfusion
(upper panel) and the endocardial transient dilation index (lower
panel) in patient cohorts grouped according to the presence of
electrocardiographic changes (ECG1) and chest pain during exercise.
Data are reported as mean value 6SE. *p , 0.01 versus other groups.
Figure 3. Bar graphs showing the extent of reversible hypoperfusion
(upper panel) and the endocardial transient dilation index (lower
panel) in different subgroups of patients with (open bars) and without
(closed bars) chest pain during exercise. Data are reported as mean
value 6SE. *p , 0.01. MI 5 myocardial infarction; MVD 5 multives-
sel disease; SVD 5 single-vessel disease.
Table 3. Multivariate Predictors of Painful Reversible
Perfusion Defect
Variable
Chi
Square
p
Value
History of effort angina 58.0 , 0.0001
Exercise ST segment depression 20.3 , 0.0001
% max age-predicted HR achieved 16.6 , 0.0001
Reversible defect extent 9.6 , 0.01
Body mass index 6.1 , 0.05
No previous MI 5.0 , 0.05
MI 5 myocardial infarction; other abbreviations as in Table 2.
951JACC Vol. 29, No. 5 MARCASSA ET AL.
April 1997:948–54 SILENT AND PAINFUL ISCHEMIA
have been changed as a consequence of the scar) were more
likely to experience silent ischemia. The use of antianginal
medications, including nitrates at the time of the rest scan, was
significantly more common in patients with painful ischemia
(Table 1). We (23) previously reported that an improved
sestamibi uptake in areas showing rest perfusion defects can
occur when the tracer injection is preceded by nitroglycerin
administration. Thus, we cannot exclude some underestima-
tion of the extent of reversible hypoperfusion in patients with
silent ischemia as a result of overestimating the “fixed” tracer
uptake defect.
Comparison with previous studies. There is persisting un-
certainty as to whether the amount of myocardium involved
during an ischemic episode is similar in patients with and
without pain. Conflicting data concerning differences in the
degree of transient ventricular impairment (24–27) and in the
angiographic extent of coronary artery disease between pa-
tients with and without exercise angina (11,14,28,29) have been
reported. Discordant results have also been reported in 10
previous studies that used myocardial perfusion scintigraphy to
compare the amount of ischemic myocardium in patients with
and without chest pain during exercise testing (Table 4).
Different imaging techniques (either planar or tomographic)
and methods of analysis (either qualitative or semiquantita-
tive) were used in these studies evaluating patients with a
variety of coronary syndromes.
To our knowledge, this is the largest study comparing the
degree of hypoperfusion and the presence of symptoms during
exercise stress testing in a consecutive cohort of highly selected
patients with ischemic heart disease. In contrast to other large
studies that enrolled subjects unselectively (14,15,19) or used
the presence of scintigraphic abnormalities as inclusion criteria
independently of a pretest analysis of coronary artery disease
probability (13,17), we focused on patients with unequivocal
evidence of reversible hypoperfusion during exercise and a well
established history of coronary artery disease (angiographic
evidence in nearly 50% of the cohort, a history of previous
myocardial infarction in an additional 20% and a high pretest
probability combined with an abnormal scintigraphic scan in
the remaining 33%). We used the 99mTc-labeled tracer sesta-
mibi, whose physical characteristics are more suitable for
tomographic imaging than are those of thallium-201, particu-
larly in overweight patients. Moreover, we used a quantitative
technique to assess the extent of myocardial hypoperfusion.
The occurrence of transient dilation of the left ventricle on
post-stress thallium-201 (30) as well as sestamibi (31) images
has been reported to be a clinically useful marker of severe and
extensive coronary artery disease. Our study patients with
painful ischemia also showed a greater endocardial TDI. Our
sestamibi images were acquired on average 60 min after tracer
injection, so it is unlikely, although not impossible, that this
finding is related to a persistent myocardial stunning affecting
wall motion and, through the partial volume effect, wall
thickness, thus simulating a transient cavity dilation. Although
the limitations of assessing ventricular volume changes solely
on the basis of a midventricular short-axis view should not be
disregarded, a likely cause for a greater endocardial (but not
epicardial) TDI in our study is the presence of some subendo-
cardial hypoperfusion, more pronounced in the group with
painful than with silent ischemia, thus supporting the impres-
sion of a greater ischemic burden in patients with chest pain.
Pain perception and complaint. The results of this study
indicate that exertional angina is related to the extent of
provoked ischemia. However, the finding of severe reversible
hypoperfusion was not uncommon in patients with silent
exertional ischemia. One may also wonder if in our asymptom-
atic patients the amount of exercise-induced ischemia was not
largely related to the longer exercise duration and higher peak
rate-pressure product achieved. Severe exertional ischemia
was silent in nearly 50% of the cases. It is unclear how much
Table 4. Thallium-201 Myocardial Perfusion Scintigraphic Studies Comparing the Amount of Ischemic Myocardium in Patients With or
Without Chest Pain During Exercise Testing
First Author Year
Pts
(no.) Method Selection Criteria
Reversible
Defects
(% of Pts)
Amount of Ischemia Equal in Patients With or Without Chest Pain
Hecht (11) 1989 112 SPECT CAD; reversible defects 100%
Gasperetti (12) 1989 103 Planar Reversible defects 100%
Heller (13) 1990 234 Planar Reversible defects 100%
Mahamarian (14) 1990 356 SPECT Unselected 54%*
Bandu (19) 1994 294 SPECT Unselected 94%
Amount of Ischemia Greater in Patients With Than Without Chest Pain
Kurata (15) 1990 471 SPECT Unselected 37%
Galli (16) 1990 200 Planar Old MI; reversible defects 100%
Travin (17) 1991 268 Planar Reversible defects 100%
Hendler (18) 1992 152 SPECT Ex ECG1 83%
Klein (9) 1994 117 SPECT Ex ECG1 80%
*In patients with coronary artery disease (CAD). Ex ECG1 5 positive exercise electrocardiogram; MI 5 myocardial infarction; Pts 5 patients; SPECT 5
single-photon emission computed tomography.
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the nature of the ischemic stimulus itself or the cognitive
mechanisms for perceiving and reporting the symptom deter-
mine whether an event is painful (5,6,10,22). More attention
has been recently focused on regional brain activation in
response to noxious stimuli (7) as well as the interactions
between behavioral patterns and the cognitive processes influ-
encing perception of ischemic symptoms (8,22). Conflicting
results have been reported (22,32,33) concerning the psycho-
logic correlates of sensitivity to painful symptoms and
symptom-reporting behavior in the patient with silent or
symptomatic ischemia. There is now some evidence (7) that
the absence of pain during myocardial ischemia may be related
to an abnormal central nervous system handling of afferent
nociceptive messages. Rosen et al. (7) compared changes in
regional cerebral blood flow during symptomatic and silent
myocardial ischemia. Despite a comparable degree of thalamic
activation shown in both angina and silent ischemia, they found
a lesser extent of cortical activation in patients with painless
ischemia, suggesting some gating of afferent stimuli at the
thalamic level. The complex interaction between location and
size of the myocardial ischemic burden, behavioral patterns
and the cognitive processes handling the ischemia-related
signals was recently discussed by Pepine (8).
Study limitations. In this study, we adopted the scinti-
graphic finding of a reversible sestamibi uptake defect as the
reference standard for exercise-induced ischemia. This as-
sumption is widely accepted in clinical practice. Compared
with angiographic results, a reversible scintigraphic perfusion
defect better predicts the hemodynamic significance of a
stenosis, in terms of both transstenotic gradient (34) and
reduced coronary reserve (35). In experimental models (36),
the finding of a reversible scintigraphic uptake defect suggests
an underlying ischemic process. On the contrary, when consid-
ering the reliability of a reversible perfusion tracer uptake
defect as a marker of transient ischemia, the risk of underes-
timating the true extent of hypoperfusion in patients with
severe and extensive coronary disease should be emphasized
(35). Furthermore, we did not assess whether the different
amount of jeopardized myocardium observed in asymptomatic
or painful inducible ischemia could have different prognostic
implications.
Despite these limitations, the present study adds important
information on the relation between the degree of the ischemic
injury and symptoms during exercise-induced myocardial isch-
emia. Chest pain during exercise was associated with objective
measures clearly indicating a greater ischemic burden.
We are grateful to Fabio Comazzi for help with the statistical analysis and to
Rosemary Allpres, MA for editorial assistance.
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